Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 25;24(1):132.
doi: 10.1186/s12894-024-01515-7.

Perioperative management of upper tract urothelial carcinoma in the Nordic countries

Affiliations

Perioperative management of upper tract urothelial carcinoma in the Nordic countries

Kimie Oedorf et al. BMC Urol. .

Abstract

Background: Upper tract urothelial carcinoma (UTUC) is a rare malignancy, with typically only few new cases annually per urological department. Adherence to European association of urology (EAU) guidelines on UTUC in the Nordic countries is unknown. The objective of this survey was to examine the implementation of EAU guidelines, the perioperative management and organization of the treatment of UTUC in the Nordic countries.

Methods: The electronic survey was distributed to 93 hospitals in the Nordic countries performing radical nephroureterectomy (NU). The survey consisted of 57 main questions and data was collected between December 1st, 2021 and April 23rd, 2022.

Results: Overall response rate was 47/93 (67%) with a completion rate of 98%. Five out of the 6 examined subjects on diagnostic practice are applied by ≥ 72% of the participating centers. NU as treatment for high-risk UTUC is performed by 37/47 (79%), and 91% include a bladder cuff excision.

Conclusions: Adherence to EAU guidelines is high on diagnostic practice in the Nordic countries, whereas disease management is less coherent.

Keywords: Guideline; Nephroureterectomy; Survey; Upper tract urothelial carcinoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Organization by subspecialty of treatment
Fig. 2
Fig. 2
Adherence to EAU guidelines on diagnostic
Fig. 3
Fig. 3
Adherence to EAU guidelines on treatment
Fig. 4
Fig. 4
a: Difference in length of stay between high- and low-volume centers. b: Usage of intravesical chemotherapy in high- and low-volume centers

References

    1. Soria F, Shariat SF, Lerner SP, Fritsche HM, Rink M, Kassouf W, et al. Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC) World J Urol. 2017;35:379–87. doi: 10.1007/s00345-016-1928-x. - DOI - PubMed
    1. Rouprêt M, Babjuk M, Compérat E, Gontero P, Liedberg F, Masson-Lecomte A et al. Upper Urinary Tract Urothelial Carcinoma EAU Guidelines on. 2022.
    1. Lughezzani G, Jeldres C, Isbarn H, Sun M, Shariat SF, Widmer H, et al. Temporal stage and grade migration in surgically treated patients with upper tract urothelial carcinoma. BJU Int. 2010;105:799–804. doi: 10.1111/j.1464-410X.2009.08818.x. - DOI - PubMed
    1. Hendricksen K, Aziz A, Bes P, Chun FKH, Dobruch J, Kluth LA, et al. Discrepancy between European Association of Urology Guidelines and Daily Practice in the management of non–muscle-invasive bladder Cancer: results of a European Survey. Eur Urol Focus. 2019;5:681–8. doi: 10.1016/j.euf.2017.09.002. - DOI - PubMed
    1. Gontero P, Babjuk M. Swedish national guidelines on urothelial cancer echo the EAU guidelines but with some regional dialect. Scandinavian J Urol. 2022;56:147–8. doi: 10.1080/21681805.2022.2057585. - DOI - PubMed

MeSH terms